• Clinical Evidence

Improvement in Hypoglycemia Rates with EndoTool IV

Image
Setting: Atrium Health Wake Forest Baptist Medical Center

Objective

This study examines clinical outcomes following the implementation of a computerized glucose management system (EndoTool) in two intensive care units that treat the majority of DKA admissions at Atrium Health Wake Forest Baptist Medical Center.

Setting

885-bed tertiary-care hospital in Winston-Salem, North Carolina.

Results

  • Adoption of EndoTool IV was associated with an approximate 5-fold reduction in hypoglycemic BG values.
  • Elimination of observed severe hypoglycemic BG values.
  • Reduction in length of stay for DKA.

Conclusions

The authors concluded that EndoTool is effective in reducing hypoglycemic events in persons treated with intravenous insulin infusions (IVI) and may reduce DKA length of stay. Hospital systems considering a quality improvement project to reduce inpatient hypoglycemia for IVI should consider adoption of a computerized glucose management system such as EndoTool.

Objective

This study examines clinical outcomes following the implementation of a computerized glucose management system (EndoTool) in two intensive care units that treat the majority of DKA admissions at Atrium Health Wake Forest Baptist Medical Center.

Setting

885-bed tertiary-care hospital in Winston-Salem, North Carolina.

Results
  • Adoption of EndoTool IV was associated with an approximate 5-fold reduction in hypoglycemic BG values.
  • Elimination of observed severe hypoglycemic BG values.
  • Reduction in length of stay for DKA.
Conclusions

The authors concluded that EndoTool is effective in reducing hypoglycemic events in persons treated with intravenous insulin infusions (IVI) and may reduce DKA length of stay. Hospital systems considering a quality improvement project to reduce inpatient hypoglycemia for IVI should consider adoption of a computerized glucose management system such as EndoTool.

References

Authors

Joseph A. Aloi, MD

Source

American Diabetes Association 83rd Scientific Sessions June 23-26

Year

2023

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This study examines clinical outcomes following the implementation of a computerized glucose management system (EndoTool) in two intensive care units that treat the majority of DKA admissions at Atrium Health Wake Forest Baptist Medical Center.

Setting

885-bed tertiary-care hospital in Winston-Salem, North Carolina.

Results
  • Adoption of EndoTool IV was associated with an approximate 5-fold reduction in hypoglycemic BG values.
  • Elimination of observed severe hypoglycemic BG values.
  • Reduction in length of stay for DKA.
Conclusions

The authors concluded that EndoTool is effective in reducing hypoglycemic events in persons treated with intravenous insulin infusions (IVI) and may reduce DKA length of stay. Hospital systems considering a quality improvement project to reduce inpatient hypoglycemia for IVI should consider adoption of a computerized glucose management system such as EndoTool.

References

Authors

Joseph A. Aloi, MD

Source

American Diabetes Association 83rd Scientific Sessions June 23-26

Year

2023

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.